← Full ankle swelling algorithm
Reasoning GP · Algorithm · 1-page summary

Ankle swelling — new presentation

For: adults with new unilateral or bilateral ankle or leg swelling in primary care. Not for: children; established leg ulcers (use the leg ulcers algorithm). Pregnancy from 20 weeks or after the birth: check BP and urine every time (block 2).
Reviewed October 2026 · next review April 2027
NICE NG158NG106NG12NG203NWCSP
Core rule: unilateral versus bilateral splits the differential. A single hot, swollen calf is a DVT until excluded; symmetrical pitting oedema points to a systemic or drug cause. Always examine both legs together.

0Stop — call 999 now — before any history

  • Sudden severe leg swelling with collapse, or a pale or mottled limb (phlegmasia cerulea dolens, ileofemoral DVT) → 999
  • Unstable: haemodynamic instability, shock, suspected massive PE, acute pulmonary oedema, severe hypoxaemia → 999
  • Acute severe unilateral leg pain or pallor (acute limb ischaemia) → 999
  • Pregnant or recently delivered with seizure, collapse or instability (eclampsia, HELLP) → 999

1Triage by pattern — unilateral or bilateral, pitting or not

PatternFirst move
Unilateral, hot, tenderRecent travel, surgery, immobility → DVT pathway Same-day
Unilateral + feverSpreading erythema, lymphangitis → cellulitis Same-day; admit if septic
Bilateral + breathlessOrthopnoea, PND, raised JVP, crackles → suspected heart failure Same-day
Bilateral pitting, wellDrug review, urinalysis, BP; bloods by picture
Non-pittingLymphoedema, myxoedema (TSH), lipoedema (spares the feet)

2Screen — one row is enough

  • DVT (two-level Wells): ≥2 → leg-vein USS within 4 h, or D-dimer + interim anticoagulation + USS within 24 h. ≤1 → D-dimer within 4 h; positive → USS as above Same-day
  • Pregnancy ≥20 weeks or postpartum: new BP ≥140/90, proteinuria, sudden swelling of face, hands or feet, headache, visual or epigastric symptoms — even with a normal BP → Same-day maternity
  • Nephrotic: facial and ankle oedema, frothy urine, marked proteinuria → Same-day
  • Liver: jaundice, new ascites → Same-day
  • Cancer: unexplained lymphadenopathy or splenomegaly → consider Suspected cancer pathway (NG12). Unexplained unilateral swelling: examine abdomen, pelvis, groin and nodes; a mass follows its NG12 site pathway.

3Assess — targeted, not blanket

☐ BP, HR, RR, temperature, SpO₂, weight  ☐ JVP, heart sounds, chest, abdomen (liver, ascites, spleen)  ☐ Both legs: symmetry, pitting, skin, varicosities, pulses, capillary refill, Stemmer sign  ☐ Urinalysis  ☐ By picture: U&E, albumin + LFT, FBC, TSH, urine ACR/PCR

NT-proBNP if heart failure suspected: <400 ng/L makes it less likely, not excluded; 400–2000 → specialist and echo within 6 weeks; >2000 → within 2 weeks (NG106).

Avoid: Homan's sign; extensive tests after a recent CCB start with no heart-failure features — switch first.

4Classify — only if the screen is negative

  • Venous insufficiency (commonest) — worse through the day, varicosities, haemosiderin, lipodermatosclerosis → compression once arterial supply assessed.
  • Drug — onset after amlodipine/CCB, NSAID, steroid, gabapentinoid, glitazone, oestrogen, minoxidil → switch or review.
  • Cardiac — orthopnoea, PND, raised JVP, crackles → NT-proBNP pathway, ECG.
  • Renal / hepatic — proteinuria, low albumin; ascites, stigmata → ACR, eGFR, LFT, albumin, INR.
  • Lymphoedema — foot dorsum involved, skin thickening; Stemmer supports, does not exclude → lymphoedema clinic. Hypothyroid — non-pitting → TSH.
  • Uncertain — say so. Call it idiopathic only once venous, dependent and drug causes are excluded; review in 2–4 weeks.

5Treat today — doses: NICE/SPC, BNF, local formulary

  • DVT confirmed: rivaroxaban 15 mg BD for 21 days then 20 mg OD with food, or apixaban 10 mg BD for 7 days then 5 mg BD; at least 3 months. Check CrCl (Cockcroft–Gault), weight, FBC, liver function, bleeding risk, interactions. Specialist: CrCl <15, active cancer, antiphospholipid syndrome, pregnancy.
  • Congestion (cardiac, renal, hepatic): loop diuretic at the lowest effective dose per local protocol; U&E at 1 week if higher risk.
  • Venous: compression only after pulses and arterial risk checked (ABPI or toe pressure where indicated); not in decompensated HF, acute DVT or severe PAD.
  • Self-care: leg elevation, walking and ankle exercises, weight loss, skin care. No routine salt or fluid restriction in heart failure (NG106).

6Refer routinely

  • Suspected or confirmed lymphoedema → lymphoedema clinic (diuretics do not treat it).
  • Non-healing venous ulcer, severe varicosities, or arterial disease found before compression → vascular / local leg-ulcer pathway.
  • Nephrology (NG203): KFRE >5%, ACR ≥70 mg/mmol, ACR >30 + haematuria, sustained eGFR fall; eGFR <30 not known to nephrology (local). Refractory oedema → HF/renal team.

7Never reassure by

  • Amlodipine on the drug chart when the patient is breathless.
  • A low NT-proBNP when suspicion remains (obesity, on HF drugs).
  • A normal BP in a pregnant woman with pre-eclampsia symptoms.
  • A negative Homan's or Stemmer sign.
  • "Idiopathic" before venous, drug and dependent causes are excluded.
  • "Lymphoedema" in a unilateral leg without examining abdomen, pelvis, groin and nodes.

8Safety-net — say it, then document it

999 “Call 999 for sudden severe breathlessness, chest pain, collapse, or a leg that suddenly becomes severely painful or pale.” Same-day “Contact us today if the swelling spreads quickly, one leg becomes painful and warm, you get new or worse breathlessness, a fever or spreading redness, your skin turns yellow or your tummy swells, or your weight rises past your heart-failure plan. If pregnant: sudden swelling of the face, hands or feet, a bad headache, vision problems, upper tummy pain or vomiting — call your maternity unit.”

Follow-up: swelling and weight at 2–4 weeks (resolution after a drug switch); DVT anticoagulation review at 3 months.

✓Safe to leave primary care only if — all five, documented

No block 0–2 row applies Both legs examined: pitting, skin, pulses Urinalysis and BP done (pregnancy: urine protein) Drug review done; cause named or uncertainty stated Review date set; safety-net given
Summary of the full Reasoning GP ankle swelling algorithm, which holds the detail, examination, investigations and evidence. Sources: NICE NG158, NG106, NG12 (updated April 2026), NG203, NG145; National Wound Care Strategy Programme; local DOAC guidance. Clinical reference — follow local pathways and check doses: NICE/SPC, BNF.